Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species.
about
Metabolism of kidney cancer: from the lab to clinical practiceHypoxia-inducible factors and the response to hypoxic stressState of the science: an update on renal cell carcinomaMitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?Targeted therapeutic strategies for the management of renal cell carcinomaMetabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effectThe complexity of the Nrf2 pathway: beyond the antioxidant responseReduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2α accumulation and promotes migration and invasionMetabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinomaRole of mitochondrial dysfunction in cancer progressionIntegrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasmsWarburg effect's manifestation in aggressive pheochromocytomas and paragangliomas: insights from a mouse cell model applied to human tumor tissue.Molecular markers of paragangliomas/pheochromocytomasUOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.Intracellular succinylation of 8-chloroadenosine and its effect on fumarate levels.The NADPH oxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberinUp-regulation of mitochondrial antioxidation signals in ovarian cancer cells with aggressive biologic behavior.Molecular diagnosis and therapy of kidney cancer.The genetic basis of kidney cancer: a metabolic diseaseThe oncometabolite fumarate promotes pseudohypoxia through noncanonical activation of NF-κB signalingAerobic glycolysis: a novel target in kidney cancer.Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.NRF2 and cancer: the good, the bad and the importance of context.Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer.Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinomaExploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCCThe proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling.Emerging metabolic targets in cancer therapyFumarate induces redox-dependent senescence by modifying glutathione metabolism.New insights into the biology of renal cell carcinomaThe glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer.Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancerMolecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer.Aerobic glycolysis tunes YAP/TAZ transcriptional activityThe relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells.Cellular metabolism and disease: what do metabolic outliers teach us?RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect.A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer.Modeling dioxygenase enzyme kinetics in familial paraganglioma.
P2860
Q24600512-2CADCC1D-810F-4892-8F51-38AA650DF82FQ24629323-5F12C967-EBA9-415E-AA16-2F314AC1A94DQ24630685-4A236E25-C0FA-4A0D-AD1F-B939636AD9DDQ26852282-1F964CD9-719B-4DEF-9341-46DC43721878Q27013846-65A7D13B-3130-4467-B101-9AAD072E288EQ27024293-5E58FFEC-93A3-4E4D-A202-0C7C5A545485Q28389296-C45A3E7C-6608-4876-B9CE-DC2115A17B61Q28478577-2CA35E1B-D3BB-4811-8440-1F244953163BQ28535371-5F78C23B-61B0-47B0-AEE7-3EF2440BD20CQ28829644-DC6AF5DA-7B5F-4714-8C40-AF26B9D96845Q31077729-AFC4C334-12BA-4C7E-A082-9E64B72E7F4FQ31079334-2EE43A2C-1C77-452D-85EB-155441C6175EQ33649025-A18A5A81-6C30-4EB6-A21D-AD64229D8196Q33682182-EFB23A22-9FEE-434E-8755-C821A9D13E3CQ33707009-45AFC710-CA3B-45ED-911E-2BFEF75CF52FQ33816437-301A3910-5698-42A9-8282-DE9681C253C3Q33884481-49978E74-84C9-4518-BE75-C96AF1BDC9FFQ34065685-9E398903-6507-4F1C-A7B1-2E79792E4B2AQ34087148-13E6AEAB-0CE0-4368-8AC9-F9B5E17EECC9Q34107403-330A6228-7351-4A1D-847F-7F2850505592Q34194088-56CAE70E-C791-4796-9210-7420B7325DACQ34208791-2D7A1534-4B2A-4E13-8500-F99E71E656F8Q34289003-BC6075BB-81E0-45E3-8A87-CDD786B3B8F3Q34336619-E7B4FC62-92E0-4265-9826-C33ECCE6F50EQ34659918-3D514762-ACB6-468C-B6A5-685A24F8C4C7Q34663243-5458495F-2F3B-4F49-9022-D15DE8836B74Q34762767-B176AE38-FBA6-45A1-A7B5-A445C1637955Q35052021-79CE980C-BD4E-4D38-A82A-D1C7E5D84257Q35121732-259339D1-2B8B-4076-A6C0-BE196232C912Q35180400-5EA50E6A-6254-4B1B-842C-E611E9417ADEQ35215557-2743E7AF-5D95-498B-B613-A700FFE65039Q35278899-13E20F5D-CB24-4ED0-9D21-A64EB3AD92F4Q35619919-C83660CE-F18C-4F60-BA05-E945791DD250Q35659640-E13940DF-D41D-4534-87DB-3DDCDD79632FQ35819661-E11114ED-FFC7-4C99-A5E8-80BA46F42654Q35889790-BFC04889-E79C-4592-B275-B39FB30B2778Q35915928-AC37DC0D-98B3-48E1-B1AC-EE064167A831Q36026989-CCAE7ACC-D2C6-4A91-A496-58439B5E7663Q36153426-FDD209D7-7562-48F4-AD50-7913D547DAFFQ36175345-6ECEEF49-8598-408E-BD96-3FF94BBC78D7
P2860
Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fumarate hydratase deficiency ...... on of reactive oxygen species.
@en
Fumarate hydratase deficiency ...... on of reactive oxygen species.
@nl
type
label
Fumarate hydratase deficiency ...... on of reactive oxygen species.
@en
Fumarate hydratase deficiency ...... on of reactive oxygen species.
@nl
prefLabel
Fumarate hydratase deficiency ...... on of reactive oxygen species.
@en
Fumarate hydratase deficiency ...... on of reactive oxygen species.
@nl
P2093
P2860
P921
P356
P1476
Fumarate hydratase deficiency ...... ion of reactive oxygen species
@en
P2093
Bradley Scroggins
Carole Sourbier
Cynthia Galindo
Hye-Sik Kong
Jane Trepel
Karen Block
Len Neckers
Mehdi Mollapour
Min-Jung Lee
Norman Goode
P2860
P304
P356
10.1128/MCB.00483-09
P407
P577
2009-05-26T00:00:00Z